Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Teerlink

Showing results (31-40 of 351) with videos related to

Pageof 36
Sort By:
Circulation Research|May 13, 2021
Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart FailureJoyce N Njoroge, John R Teerlink
Handbook of Experimental Pharmacology|March 19, 2017
Direct Myosin Activation by Omecamtiv Mecarbil for Heart Failure with Reduced Ejection FractionMitchell A Psotka, John R Teerlink
Current Treatment Options in Cardiovascular Medicine|July 2, 2003
Novel Pharmacologic Therapy of Heart FailureSteven J. Hussein, John R. Teerlink
Circulation|March 30, 2005
Nesiritide and worsening of renal function: the emperor's new clothes?John R Teerlink, Barry M Massie
Expert Opinion on Pharmacotherapy|February 3, 2007
Nesiritide: a reappraisal of efficacy and safetySanjiv J Shah, John R Teerlink
European Heart Journal|April 16, 2016
Lung ultrasound: a 'B-line' to the prediction of decompensated heart failureMandar A Aras, John R Teerlink
Heart Failure Clinics|July 6, 2015
Team-based Care for Patients Hospitalized with Heart FailurePaul M Larsen, John R Teerlink
European Journal of Heart Failure|July 17, 2015
Cardiac myosin activators: up and comingMitchell A Psotka, John R Teerlink
Journal of Cardiac Failure|June 20, 2003
Late breaking heart failure trials from the 2003 ACC meeting: EPHESUS and COMPANIONJohn R Teerlink, Barry M Massie,
JACC. Heart Failure|June 11, 2018
Patient-Reported Outcome Instruments in Heart Failure: Are They Preserved?Mitchell A Psotka, John R Teerlink
Pageof 36

Showing results (31-40 of 351) with videos related to

Sort By:
Pageof 36
Circulation Research|May 13, 2021
Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart FailureJoyce N Njoroge, John R Teerlink
Handbook of Experimental Pharmacology|March 19, 2017
Direct Myosin Activation by Omecamtiv Mecarbil for Heart Failure with Reduced Ejection FractionMitchell A Psotka, John R Teerlink
Current Treatment Options in Cardiovascular Medicine|July 2, 2003
Novel Pharmacologic Therapy of Heart FailureSteven J. Hussein, John R. Teerlink
Circulation|March 30, 2005
Nesiritide and worsening of renal function: the emperor's new clothes?John R Teerlink, Barry M Massie
Expert Opinion on Pharmacotherapy|February 3, 2007
Nesiritide: a reappraisal of efficacy and safetySanjiv J Shah, John R Teerlink
European Heart Journal|April 16, 2016
Lung ultrasound: a 'B-line' to the prediction of decompensated heart failureMandar A Aras, John R Teerlink
Heart Failure Clinics|July 6, 2015
Team-based Care for Patients Hospitalized with Heart FailurePaul M Larsen, John R Teerlink
European Journal of Heart Failure|July 17, 2015
Cardiac myosin activators: up and comingMitchell A Psotka, John R Teerlink
Journal of Cardiac Failure|June 20, 2003
Late breaking heart failure trials from the 2003 ACC meeting: EPHESUS and COMPANIONJohn R Teerlink, Barry M Massie,
JACC. Heart Failure|June 11, 2018
Patient-Reported Outcome Instruments in Heart Failure: Are They Preserved?Mitchell A Psotka, John R Teerlink
Pageof 36